Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript

And as they succeed, and with that platform moving forward, they’ll create a consumable and reagent stream for us. And if there’s an opportunity which we believe there is, to take that solution beyond the US and into other markets, that creates both test revenue and consumer reagent and system revenue opportunities. None of this is what I would call immediate near term impact, but it’s really solid long term strategy.

Conor McNamara: Great. Thanks for that color, Andy. And I don’t know if this is your last earnings call, but if so, best of luck in retirement. And Roop, welcome to the team. Thanks guys.

Roop Lakkaraju: Just to be clear, it won’t be Andy’s last earnings call. We’ve made sure of that. Thank you. Well, thank you.

Operator: Thank you. [Operator instructions]. And gentlemen, it appears we have no further questions this afternoon. Mister Chung? I’d like to turn things back to you, sir, for any closing comments.

Edward Chung: Yes. Thank you for joining today’s call. We will be at the RBC Capital Markets Global Healthcare conference in New York next week, and we’ll be back in New York in June for the Jefferies healthcare conference. So, as always, we appreciate your interest and we look forward to connecting soon. Thanks.

Operator: Thank you Mister Chung. We will conclude the Bio-Rad’s first quarter earnings results call, again thanks so much all for joining us and we wish you all a great day. Good bye.